Silverback Therapeutics
500 Fairview Avenue, North
Suite 600
Seattle
Washington
98109-5506
United States
Tel: 206-456-2900
About Silverback Therapeutics
Silverback Therapeutics, a stealthy biotech startup co-founded by investor, entrepreneur and University of Washington neurosurgery professor Peter Thompson.
YEAR FOUNDED:
2016
LEADERSHIP:
Founder: Peter Thompson
7 articles about Silverback Therapeutics
-
Like the Grinch’s heart at Christmas, the Nasdaq Exchange grew a little bigger this week with multiple life science companies raising hundreds of millions of dollars in initial public offerings.
-
Silverback Therapeutics Raises $78.5 Million to Advance Cancer Antibody Conjugates for Solid Tumors
3/11/2020
The financing round brings the company’s total investments up to about $125 million. -
Silverback Therapeutics to Present Data for Lead Therapeutic Candidate SBT6050 at American Association of Cancer Research Annual Conference
2/27/2019
Novel composition design allows for systemic delivery of TLR8 with activity localized to HER2-expressing tumors
-
The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics.
-
With Ex-Juno Employees on Its Roster, Seattle's Silverback Therapeutics Files $10 Million Out of $60 Million Goal
2/16/2017
-
NanoString Expands; New Biotech Silverback Therapeutics Sets Up Shop
7/14/2016